Zenith Suspension Use In Pregnancy & Lactation

Pregnancy: There are no adequate and well controlled studies in pregnant women. Animal reproduction studies show passage across the placenta. No teratogenic effects were observed in rat reproduction studies (see Pharmacology: Toxicology: Preclinical Safety Data under Actions). The safety of Azithromycin monohydrate (Zenith) has not been confirmed with regard to the use of the active substance during pregnancy. Therefore Azithromycin monohydrate (Zenith) should only be used in life threatening cases during pregnancy.
Lactation: Azithromycin monohydrate (Zenith) passes into breast milk. Because it is not known whether Azithromycin monohydrate (Zenith) may have adverse effects on the breast-fed infant, nursing should be discontinued during treatment with Azithromycin monohydrate (Zenith). Among other things, diarrhea, fungi infection of the mucus membrane as well as sensitization is possible in the nursed infant. It is recommended to discard the milk during treatment and up until 2 days after discontinuation of treatment. Nursing may be resumed thereafter.